Long COVID headache
Claudio Tana(Ospedale SS. Annunziata), Paolo Martelletti(Unitelma Sapienza University), Bianca Raffaelli(Humboldt-Universität zu Berlin), Enrico Bentivegna(Azienda Ospedaliera Sant'Andrea), Ruth Ruscheweyh(Technical University of Munich), Andrea M. Harriott(Harvard University), Alejandro Labastida‐Ramírez(University of Manchester), Raffaele Ornello(University of L'Aquila), Soo‐Jin Cho(Hallym University Dongtan Sacred Heart Hospital), Eloísa Rubio‐Beltrán(King's College London), David García‐Azorín(Universidad de Valladolid)
Cited by 158
Related Papers
3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cells
|Scientific Reports|2017|176
Hallmarks of primary headache: part 1 – migraine
|The Journal of Headache and Pain|2024|169
Applying a biopsychosocial model to migraine: rationale and clinical implications
|The Journal of Headache and Pain|2022|148
Functional connectivity studies in migraine: what have we learned?
|The Journal of Headache and Pain|2019|107
Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection
|American Journal of Infection Control|2020|103